These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 30501594)
1. Targeting the Ribosome Biogenesis Key Molecule Fibrillarin to Avoid Chemoresistance. El Hassouni B; Sarkisjan D; Vos JC; Giovannetti E; Peters GJ Curr Med Chem; 2019; 26(33):6020-6032. PubMed ID: 30501594 [TBL] [Abstract][Full Text] [Related]
2. Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer. Nguyen Van Long F; Lardy-Cleaud A; Carène D; Rossoni C; Catez F; Rollet P; Pion N; Monchiet D; Dolbeau A; Martin M; Simioni V; Bray S; Le Beherec D; Mosele F; Bouakka I; Colombe-Vermorel A; Odeyer L; Diot A; Jordan LB; Thompson AM; Jamen F; Dubois T; Chabaud S; Michiels S; Treilleux I; Bourdon JC; Pérol D; Puisieux A; André F; Diaz JJ; Marcel V BMC Cancer; 2022 May; 22(1):526. PubMed ID: 35545761 [TBL] [Abstract][Full Text] [Related]
3. p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer. Marcel V; Ghayad SE; Belin S; Therizols G; Morel AP; Solano-Gonzàlez E; Vendrell JA; Hacot S; Mertani HC; Albaret MA; Bourdon JC; Jordan L; Thompson A; Tafer Y; Cong R; Bouvet P; Saurin JC; Catez F; Prats AC; Puisieux A; Diaz JJ Cancer Cell; 2013 Sep; 24(3):318-30. PubMed ID: 24029231 [TBL] [Abstract][Full Text] [Related]
4. Splicing factor 2-associated protein p32 participates in ribosome biogenesis by regulating the binding of Nop52 and fibrillarin to preribosome particles. Yoshikawa H; Komatsu W; Hayano T; Miura Y; Homma K; Izumikawa K; Ishikawa H; Miyazawa N; Tachikawa H; Yamauchi Y; Isobe T; Takahashi N Mol Cell Proteomics; 2011 Aug; 10(8):M110.006148. PubMed ID: 21536856 [TBL] [Abstract][Full Text] [Related]
5. Chemotherapeutic drugs inhibit ribosome biogenesis at various levels. Burger K; Mühl B; Harasim T; Rohrmoser M; Malamoussi A; Orban M; Kellner M; Gruber-Eber A; Kremmer E; Hölzel M; Eick D J Biol Chem; 2010 Apr; 285(16):12416-25. PubMed ID: 20159984 [TBL] [Abstract][Full Text] [Related]
6. Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate. Scala F; Brighenti E; Govoni M; Imbrogno E; Fornari F; Treré D; Montanaro L; Derenzini M Oncogene; 2016 Feb; 35(8):977-89. PubMed ID: 25961931 [TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of 28S ribosomal RNA in β-thalassemia trait carriers. Sornjai W; Lithanatudom P; Erales J; Joly P; Francina A; Hacot S; Fucharoen S; Svasti S; Diaz JJ; Mertani HC; Smith DR Int J Biol Macromol; 2017 Jan; 94(Pt A):728-734. PubMed ID: 27765567 [TBL] [Abstract][Full Text] [Related]
8. Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance. Elhamamsy AR; Metge BJ; Alsheikh HA; Shevde LA; Samant RS Cancer Res; 2022 Jul; 82(13):2344-2353. PubMed ID: 35303060 [TBL] [Abstract][Full Text] [Related]
9. Systematic mapping of rRNA 2'-O methylation during frog development and involvement of the methyltransferase Fibrillarin in eye and craniofacial development in Xenopus laevis. Delhermite J; Tafforeau L; Sharma S; Marchand V; Wacheul L; Lattuca R; Desiderio S; Motorin Y; Bellefroid E; Lafontaine DLJ PLoS Genet; 2022 Jan; 18(1):e1010012. PubMed ID: 35041640 [TBL] [Abstract][Full Text] [Related]
10. Analysis of the rRNA methylation complex components in pediatric B-cell precursor acute lymphoblastic leukemia: A pilot study. Ussowicz M; Marcel V; Long FNV; Kazanowska B; Diaz JJ; Wołowiec D Adv Clin Exp Med; 2020 Jan; 29(1):107-113. PubMed ID: 32011831 [TBL] [Abstract][Full Text] [Related]
11. Arabidopsis protein arginine methyltransferase 3 is required for ribosome biogenesis by affecting precursor ribosomal RNA processing. Hang R; Liu C; Ahmad A; Zhang Y; Lu F; Cao X Proc Natl Acad Sci U S A; 2014 Nov; 111(45):16190-5. PubMed ID: 25352672 [TBL] [Abstract][Full Text] [Related]
12. Ribosome biogenesis: An emerging druggable pathway for cancer therapeutics. Catez F; Dalla Venezia N; Marcel V; Zorbas C; Lafontaine DLJ; Diaz JJ Biochem Pharmacol; 2019 Jan; 159():74-81. PubMed ID: 30468711 [TBL] [Abstract][Full Text] [Related]